Outsourcing

Mobile technology and RCTs: An innovative trend on the rise

Special edition: Outsourcing

Mobile technology and RCTs: An innovative trend on the rise

By Stephen DANIELLS

Smart phones are enhancing the way CROs run clinical trials, but what's possible with mobile technology, how is the technology affecting recruitment and compliance, and how do you measure success?  

FDA agrees to new deadlines on FSMA final rules

FDA agrees to new deadlines on FSMA final rules

By Hank Schultz

The Food and Drug Administration has agreed to new deadlines for final rules detailing the implementaiton of the Food Safety Modernization Act (FSMA). The agreement comes as part of a settlement in a lawsuit brought by advocacy groups claiming that FDA...

2013’s top regulatory, policy & enforcement news

2013’s top regulatory, policy & enforcement news

By Stephen DANIELLS

From warning letters to GMO labeling and FSMA, it’s been a busy year for the regulatory people. In this special gallery we review the top regulatory, policy & enforcement headlines from 2013. 

Despite bad publicity, adulteration picture slowly improving, experts say

Special Edition: Botanicals

Despite bad publicity, adulteration picture slowly improving, experts say

By Hank Schultz

The extent of adulteration of herbal supplements has been a question for as long as the products have been on the market.  In light of damaging publicity, such as Monday’s article in The New York Times, is there evidence that progress is being made on...

NSF expands in Latin America with Peruvian acquisition

NSF expands in Latin America with Peruvian acquisition

By Hank Schultz

NSF International announced a significant expansion of its footprint in Latin America with the acquisition of INASSA Group of Lima, Peru.  INASSA provides technical analysis, laboratory and sanitation services. In particular, the move means NSF will be...

How to show a clinical trial benefit in healthy populations

How to show a clinical trial benefit in healthy populations

By Stephen DANIELLS

By applying physiological stressors like partial sleep deprivation, it is possible to test the effects of dietary supplements in healthy populations and stay compliant with DSHEA, says Dr Jay Udani, CEO of Medicus Research.

LIMS slowly displacing paper records in labs

LIMS slowly displacing paper records in labs

By Hank Schultz

Electronic record keeping is slowly making inroads into the analytical chemistry side of the dietary supplement business. But for many lab techs, it’s still a pencil and paper world.

With the Olympic Games approaching, NAI is predicting growing interest in its patented beta-alanine ingredient CarnoSyn

NAI posts 30% surge in sales in Q3, 2012

By Elaine Watson

California-based nutritional supplement contract manufacturer Natural Alternatives International (NAI) has posted a 30.3% rise in net sales to $17.4m in the three months to March 31, 2012.

NBTY: ‘We must generate acceptable margins in private label’

NBTY: ‘We must generate acceptable margins in private label’

By Elaine Watson

Sales of NBTY’s vitamins, minerals and health supplement (VMHS) brands grew 10% in the US food, drug and mass merchandise channel in 2011 - more than double that of industry growth of 4.5% - according to bosses at the nutritional supplements giant.

The acquisition will help deliver of a wider range of health science services for dietary supplements

NSF International acquires biotech & pharma lab company

By Mike Stones

NSF International’s acquisition of Connecticut-based contract laboratory Pharmalytica Services will allow the company to deliver of a wider range of health science services to the dietary supplements, biotech, pharmaceutical and medical device industries,...

Follow us

Products

View more

Webinars